Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update.
Shanghai Henlius Biotech, Inc. has announced a board meeting scheduled for August 26, 2024, to discuss and approve its interim results for the first half of the year ending June 30, 2024, and to consider the declaration of an interim dividend. The meeting will address other business matters as well. This event could indicate upcoming financial developments for the company and its shareholders.
For further insights into HK:2696 stock, check out TipRanks’ Stock Analysis page.